Both reference products and biosimilar medicines are
made under carefully controlled conditions, known as
Good Manufacturing Practices (GMP), to ensure that
they are consistently produced to the required quality.
Viatris has a long history of manufacturing. Of our
nearly 50 manufacturing sites around the world,
12 R&D centers worldwide are developing a broad
spectrum of complex products, including biosimilars.
Scientists across a range of
disciplines in our
research facilities play a critical role
in advancing our